title: [Comparison in dissolution behavior of ethical and over-the counter scopolamine butylbromide].
abstract: Marketing authorization holders do not disclose any information on the pharmaceutical properties of over-the-counter drugs (OTC). When a drug is switched from a prescription drug to OTC, pharmacists can acquire that information from the corresponding ethical drug (ED) through the package insert, interview form, and so on. However, the pharmaceutical equivalence between ED and OTC is unclear. In this study, we examined the drug dissolution behavior of both ED and OTCs containing scopolamine butylbromide. Dissolution tests were performed by the paddle method using Japanese Pharmacopeia (JP) XV test fluids at pH 1.2, 4.0 and 6.8 and water based on the guidelines for bioequivalence studies of generic products. The dissolution profiles of OTCs differed significantly from ED showing a similarity factor (f2) value ranging from 8.9 to 42.9. Time until 85% dissolution ranged from 23 to 95 min and from 17 to 174 min at pH 1.2 and pH 6.8, respectively. Then JP XV disintegration tests were conducted to investigate differences in the disintegration process. The disintegration time of preparations showing delayed dissolution was prolonged compared to that of others, suggesting that the disintegration of the tablet or capsule is one of the important factors affecting the drug dissolution. These differences in the disintegration and drug dissolution might cause differences in the bioavailability of the drug. For patient safety, more detailed product information of OTCs should be supplied by the manufacturer, and not be assumed from that of corresponding ED.
authors: Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
authors: Ichie
authors: I
authors: Suzuki
authors: Yasunori
authors: Y
authors: Miyazaki
authors: Tomonobu
authors: T
authors: Uchino
authors: Yoshiyuki
authors: Y
authors: Kagawa
mesh_terms: D001682:Biological Availability; D002086:Butylscopolammonium Bromide; D057915:Drug Substitution; D004366:Nonprescription Drugs; D061214:Patient Safety; D055553:Prescription Drugs; D012995:Solubility; D013810:Therapeutic Equivalency; D014867:Water
chemical_list: D004366:Nonprescription Drugs; D055553:Prescription Drugs; D014867:Water; D002086:Butylscopolammonium Bromide